Fumiharu Naganeo

Title: Fumiharu Naganeo: Innovator in Drug Metabolism Evaluation

Introduction

Fumiharu Naganeo is a notable inventor based in Chita, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the evaluation of drug metabolism. His work is essential for understanding how drugs are processed in the body, which is crucial for drug development and safety.

Latest Patents

Fumiharu Naganeo holds 1 patent for his invention titled "Method for evaluating drug metabolism and reagent compositions therefor." This invention pertains to a method for assessing the susceptibility of pharmaceutical drugs to metabolism by a specific cytochrome P-450 isozyme. The method involves contacting a sample compound with a reagent composition that includes the specific cytochrome P-450 isozyme and liver microsomes that lack this isozyme. This innovative approach provides a valuable in vitro quantitative assay for drug metabolism by various P-450 isozymes, including CYP2D6, CYP2C19, and CYP2A6.

Career Highlights

Fumiharu Naganeo is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer focuses on advancing drug development processes and improving the safety and efficacy of pharmaceutical products.

Collaborations

He has collaborated with notable colleagues, including Mayumi Mizutani and Kaoru Shimada, who contribute to the research and development efforts in the field of drug metabolism.

Conclusion

Fumiharu Naganeo's innovative methods for evaluating drug metabolism represent a significant advancement in pharmaceutical research. His contributions are vital for the ongoing development of safer and more effective medications.